Literature DB >> 3568537

Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.

C L Denlinger, K K Stryker, L B Slusher, E S Vesell.   

Abstract

Theophylline metabolism was accelerated in 11 of 13 normal male volunteers who received theophylline for 1 week in usual therapeutic doses (3 mg/kg orally t.i.d.). Mean theophylline clearance increased 24% and mean salivary elimination half-life (t1/2) decreased 16%, whereas the mean apparent volume of distribution of theophylline was unchanged at 0.7 L/kg. Large variations occurred in the extent of autoinduction, ranging from no change in two subjects to doubling of theophylline clearance in two others. Subjects who accelerated their theophylline metabolism exhibited a high inverse correlation between the extent of their induction and their two control values for theophylline clearance (r = -0.88 and -0.91; P less than 0.05). A single oral dose of antipyrine (18 mg/kg) simultaneously coadministered with a single oral dose of theophylline (5 mg/kg) retarded the metabolism of both theophylline and antipyrine. No significant change occurred in the apparent volume of distribution of either drug. Coadministration with antipyrine reduced mean theophylline clearance 18% and increased salivary t1/2 39%. Theophylline decreased mean antipyrine clearance 21% and increased its mean salivary t1/2 28%. Theophylline metabolism, therefore, is sensitive to not only autoinduction when theophylline is given long term at usual therapeutic doses but also inhibition when theophylline is coadministered with certain drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3568537     DOI: 10.1038/clpt.1987.67

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Continuous adenosine A2A receptor antagonism after focal cerebral ischemia in spontaneously hypertensive rats.

Authors:  Ulrike Fronz; Alexander Deten; Frank Baumann; Alexander Kranz; Sarah Weidlich; Wolfgang Härtig; Karen Nieber; Johannes Boltze; Daniel-Christoph Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-30       Impact factor: 3.000

2.  The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion.

Authors:  A V Boddy; M Cole; A D Pearson; J R Idle
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Comparison of the in vitro dissolution properties and in vivo steady-state pharmacokinetics of two sustained-release theophylline preparations.

Authors:  J H Jonkman; W J Van der Boon; G Grasmeijer
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

4.  Genetic and environmental factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes.

Authors:  K K Norris; T M DeAngelo; E S Vesell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 5.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

6.  Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.

Authors:  E Tanaka; K Nakamura
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Felodipine reduces the absorption of theophylline in man.

Authors:  T Bratel; B Billing; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.